MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Typically moves ±5.00% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-10-15 APPROXIMATE

MADRIGAL PHARMACEUTICALS, INC. (MDGL) has reported earnings 40 times since Mar 26, 2009. The stock moves an average of ±5.00% the day after reporting, closing higher 45.0% of the time. Its largest post-earnings gain was +20.1% (Oct 31, 2024) and its largest decline was -12.18% (Aug 07, 2024). The next earnings report is predicted for 2026-10-15 (approximate).

Earnings reactions

How MDGL moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.00%

Positive %

45.0%

Negative %

55.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Jul 30, 2026	☀ PRE	-9.93%	open_in_new
May 06, 2026	☀ PRE	+7.49%	open_in_new
Feb 19, 2026	☀ PRE	-11.11%	open_in_new
Nov 04, 2025	☀ PRE	+7.83%	open_in_new
Aug 05, 2025	☀ PRE	+8.59%	open_in_new
May 01, 2025	☀ PRE	-1.86%	open_in_new
Feb 26, 2025	☀ PRE	+14.99%	open_in_new
Oct 31, 2024	☀ PRE	+20.1%	open_in_new
Aug 07, 2024	☀ PRE	-12.18%	open_in_new
May 07, 2024	☀ PRE	-7.48%	open_in_new
Feb 28, 2024	☀ PRE	+6.02%	open_in_new
Nov 06, 2023	☀ PRE	+0.33%	open_in_new
Aug 08, 2023	☀ PRE	-5.81%	open_in_new
May 09, 2023	☀ PRE	-2.99%	open_in_new
Feb 23, 2023	☀ PRE	+5.22%	open_in_new
Nov 03, 2022	☀ PRE	-6.34%	open_in_new
Aug 04, 2022	☀ PRE	+10.98%	open_in_new
May 09, 2022	☀ PRE	-10.14%	open_in_new
Feb 24, 2022	☀ PRE	+7.13%	open_in_new
Nov 04, 2021	☀ PRE	+1.66%	open_in_new
Aug 05, 2021	☀ PRE	+5.01%	open_in_new
May 06, 2021	☀ PRE	-2.2%	open_in_new
Feb 25, 2021	☀ PRE	+0.21%	open_in_new
Nov 05, 2020	☀ PRE	-4.59%	open_in_new
Aug 06, 2020	☀ PRE	-3.12%	open_in_new
May 07, 2020	☀ PRE	-0.08%	open_in_new
Feb 26, 2020	☀ PRE	-1.23%	open_in_new
Nov 06, 2019	☀ PRE	-4.58%	open_in_new
Aug 07, 2019	☀ PRE	+0%	open_in_new
May 08, 2019	☀ PRE	+0.66%	open_in_new
Feb 27, 2019	☀ PRE	-0.51%	open_in_new
Nov 06, 2018	☀ PRE	+4.18%	open_in_new
Aug 07, 2018	☀ PRE	-0.67%	open_in_new
May 08, 2018	☀ PRE	-1%	open_in_new
Mar 13, 2018	☀ PRE	-10.88%	open_in_new
Nov 09, 2017	☀ PRE	+1.25%	open_in_new
Aug 10, 2017	☀ PRE	-0.7%	open_in_new
May 11, 2017	☽ POST	-0.5%	open_in_new
Nov 14, 2016	☽ POST	+0%	open_in_new
Mar 26, 2009	☽ POST	-0.54%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.00%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 37 →

Funds holding

$3123874418

Total value held

Buying

21 added · 14 reduced

Janus Henderson Group Plc

$1051727476 NEW BUY

Blackrock, Inc.

$644753455 -23.03%

State Street Corp

$282995975 -13.53%

Ubs Group Ag

$215697110 NEW BUY

Invesco Ltd.

$161855524 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144	20260820	open_in_new SEC.gov
4	20260820	open_in_new SEC.gov
3	20260818	open_in_new SEC.gov
4	20260818	open_in_new SEC.gov
8-K	20260812	open_in_new SEC.gov
10-Q	20260730	open_in_new SEC.gov
8-K	20260730	open_in_new SEC.gov
SCHEDULE 13G/A	20260729	open_in_new SEC.gov
144	20260720	open_in_new SEC.gov
4	20260720	open_in_new SEC.gov

Frequently asked about MDGL earnings

When does MADRIGAL PHARMACEUTICALS, INC. report earnings next? expand_more

MADRIGAL PHARMACEUTICALS, INC. (MDGL)'s next earnings date is approximate for 2026-10-15. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does MDGL stock move after earnings? expand_more

Over 40 reports, MDGL has moved an average of ±5.00% the session after earnings, closing higher 45.0% of the time.

What was MDGL's biggest post-earnings move? expand_more

MDGL's largest post-earnings gain on record was +20.1% on Oct 31, 2024, and its largest decline was -12.18% on Aug 07, 2024.

Where can I find MADRIGAL PHARMACEUTICALS, INC.'s SEC filings? expand_more

All of MADRIGAL PHARMACEUTICALS, INC.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.